Search / 15040 results found

from
to

SAN DIEGO, Oct. 16, 2021 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that it will present key information from its movement disorder treatments for Parkinson's disease and tardive dyskinesia (TD) at the American Neurological Association (ANA) 2021 Virtual Annual Meeting being held October 17–19, 2021.

  • Updated

SAN DIEGO, Oct. 16, 2021 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers of InnovAge Holding Corp. (NASDAQ: INNV) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with InnovAge's March 2021 initial public offering ("IPO") have until December 13, 2021 to seek appointment as lead plaintiff in the InnovAge class action lawsuit.  The InnovAge class action lawsuit – captioned McLeod v. InnovAge Holding Corp., No. 21-cv-02770 – charges InnovAge, certain of its officers, and the underwriters of InnovAge's IPO with violations of the Securities Act of 1933.  The InnovAge class action lawsuit was commenced on October 14, 2021 in the District of Colorado. 

  • Updated

SAN DIEGO, Oct. 16, 2021 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of HyreCar Inc. ("HyreCar" or the "Company") (NASDAQ: HYRE). The class action is on behalf of shareholders who purchased HyreCar common stock between May 14, 2021 and August 10, 2021. If you wish to serve as lead plaintiff in this class action, you must move the Court no later than October 26, 2021.

  • Updated

SAN DIEGO, Oct. 16, 2021 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of loanDepot, Inc. (NYSE: LDI) ("loanDepot" or the "Company"). The class action is on behalf of shareholders who purchased loanDepot common stock pursuant or traceable to February 2021, initial public stock offering (the "IPO"). If you wish to serve as lead plaintiff in this class action, you must move the Court no later than November 8, 2021.

  • Updated

SAN DIEGO, Oct. 16, 2021 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of investors of Cassava Sciences, Inc. ("Cassava" or the "Company") (NASDAQ: SAVA). The class action is on behalf of shareholders who purchased Generac common stock between September 14, 2020 and August 27, 2021. If you wish to serve as lead plaintiff in this class action, you must move the Court no later than October 26, 2021.